What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study.

Sonia Roldan Munoz Douwe Postmus Sieta T de Vries Liana Gross-MartirosyanPriya BahriHans L Hillege Peter G M Mol

Published in: Drug safety (2023)

The opinion regarding the need to communicate safety issues was influenced by the concern of regulators. Regulators' concern was influenced by the characteristics of the safety issue, demographic characteristics, and attitudes. Diverse groups of experts regarding such factors would ensure that various views are incorporated in risk communication decisions.

Keyphrases

transcription factor
mental health
cross sectional
drug induced
breast cancer risk